Not for distribution to U.S. Newswire Services or for dissemination in the United States.
INDIVA Adds Half-Warrant to Equity Offering
LONDON, ON (Friday, September 22, 2017): INDIVA Corporation (“INDIVA” or the “Company”) is pleased to announce the addition of a half-warrant to the equity private placement offering previously announced by the Company and Rainmaker Resources Ltd. (“Rainmaker”) (TSX.V:RIR) on June 1, 2017 (the “Offering”). Each subscription receipt (“Subscription Receipt”) purchased under the Offering will now convert into a unit (“Unit”) comprising one common share (“Share”) in the capital of the issuer resulting from the amalgamation of Indiva and Rainmaker and one-half of one common share purchase warrant. Each whole warrant (“Warrant”) will entitle the holder to purchase a Share at Cdn $0.90 for a period of two years.
Pursuant to the first tranche of the Offering (the “First Tranche”), which occurred on August 28, 2017, Rainmaker raised aggregate gross proceeds of $5,755,956.75 by issuing 7,674,609 units (“Units”) at a price of $0.75 per Unit. Subsequent closings of the Offering are planned for Q3 and/or Q4 of 2017.
Sunel Securities Inc. is the Company’s exclusive agent and advisor on the Offering.
The terms of the Offering, as amended, and the reverse takeover transaction of Indiva, remain subject to TSX Venture Exchange approval.
About INDIVA
INDIVA is a Canadian supplier of high quality, medical grade cannabis. INDIVA’s strain selection, cultivation and client care processes combine the know-how and experience of an internationally recognized and award winning grow-team with GMP-compliant quality assurance standard operating procedures.
INDIVA’s wholly owned subsidiary is a Licensed Producer under Canada’s Access to Cannabis for Medical Purposes Regulation (“ACMPR”) with its first indoor cannabis production facility located in London, Ontario.
INDIVA aims to become a global marijuana brand recognized for high quality cannabis products and excellent client care. As marijuana laws liberalize in Canada, INDIVA will expand its product offering to include safe edibles and other client-friendly cannabis products. In addition, as marijuana laws liberalize internationally, INDIVA will use its Canadian operations as a platform to open new markets for its cannabis products.
CONTACT INFORMATION
INDIVA
Niel Marotta, CEO
Phone: 613-883-8541
Email: [email protected]
DISCLAIMER & READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the intention of the parties to complete the Offering and the Transaction. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary corporate, regulatory and other third parties approvals; licensing and other risks associated with regulated ACMPR entities; and completion of satisfactory due diligence. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.